What is the EV/EBITDA ratio for ProMIS Neurosciences, Inc. (PMN)?

The EV/EBITDA ratio for PMN stock is N/A.

What is the estimated TTM average EV/EBITDA ratio for ProMIS Neurosciences, Inc. (PMN)?

The estimated TTM average EV/EBITDA ratio for PMN stock is 12.88x.

ProMIS Neurosciences (PMN) EV/EBITDA: History & Chart

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T16:18:23.328Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:18:23.328Z.

Quote observation: 2026-10-06T16:13:52.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 84,520,507
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 53,429,280
TTM operating EBITDA · period ending 2026-06-30: -43,433,845

FMP input reference: b1195b951add05ab4c37664b10382d427b1d38f05de7a164f71fe4d518fffb76

EV/Sales|P/E Ratio|EBITDA|All Metrics

PMN EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

EV/EBITDA RATIO AVG TTM

12.88x

EV/EBITDA RATIO AVG 3Y

N/A

EV/EBITDA RATIO AVG 5Y

N/A

EV/EBITDA RATIO AVG 10Y

N/A

EV/EBITDA RATIO AVG 15Y

N/A

EV/EBITDA RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

PMN Competitors' EV/EBITDA Ratio

PMN

ProMIS Neurosciences, Inc.

Current

Market Cap

$84.52M

EV/EBITDA Ratio

N/A

TTM Avg

12.88x

3Y Avg

N/A

5Y Avg

N/A

CGTX

Cognition Therapeutics, Inc.

vs PMN

Market Cap

$84.57M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HUMA

Humacyte, Inc.

vs PMN

Market Cap

$84.32M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CTOR

Citius Oncology, Inc.

vs PMN

Market Cap

$83.63M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ATRA

Atara Biotherapeutics, Inc.

vs PMN

Market Cap

$85.42M

EV/EBITDA Ratio

N/A

TTM Avg

8.06x

3Y Avg

8.06x

5Y Avg

8.06x

CRDF

Cardiff Oncology, Inc.

vs PMN

Market Cap

$83.24M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACRV

Acrivon Therapeutics, Inc. Common Stock

vs PMN

Market Cap

$82.82M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LNSR

LENSAR Inc

vs PMN

Market Cap

$82.78M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MNOV

MediciNova, Inc.

vs PMN

Market Cap

$82.45M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CCLD

CareCloud, Inc.

vs PMN

Market Cap

$86.69M

EV/EBITDA Ratio

4.63x

TTM Avg

4.46x

3Y Avg

3.36x

5Y Avg

3.41x

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
ProMIS Neurosciences, Inc. (PMN)	$84.52M	N/A	12.88x	N/A	N/A
Cognition Therapeutics, Inc. (CGTX)vs ›	$84.57M	N/A	N/A	N/A	N/A
Humacyte, Inc. (HUMA)vs ›	$84.32M	N/A	N/A	N/A	N/A
Citius Oncology, Inc. (CTOR)vs ›	$83.63M	N/A	N/A	N/A	N/A
Atara Biotherapeutics, Inc. (ATRA)vs ›	$85.42M	N/A	8.06x	8.06x	8.06x
Cardiff Oncology, Inc. (CRDF)vs ›	$83.24M	N/A	N/A	N/A	N/A
Acrivon Therapeutics, Inc. Common Stock (ACRV)vs ›	$82.82M	N/A	N/A	N/A	N/A
LENSAR Inc (LNSR)vs ›	$82.78M	N/A	N/A	N/A	N/A
MediciNova, Inc. (MNOV)vs ›	$82.45M	N/A	N/A	N/A	N/A
CareCloud, Inc. (CCLD)vs ›	$86.69M	4.63x	4.46x	3.36x	3.41x

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for ProMIS Neurosciences, Inc. (PMN)?: The EV/EBITDA ratio for PMN stock is N/A.
What is the estimated TTM average EV/EBITDA ratio for ProMIS Neurosciences, Inc. (PMN)?: The estimated TTM average EV/EBITDA ratio for PMN stock is 12.88x.

PMN EV/EBITDA Ratio History

DATE	EV/EBITDA RATIO
2020-12-31	12.32x
2020-12-30	9.21x
2020-12-29	9.21x
2020-12-28	10.77x
2020-12-24	9.21x
2020-12-23	9.21x
2020-12-22	9.21x
2020-12-21	9.21x
2020-12-18	9.21x
2020-12-17	9.21x
2020-12-16	9.21x
2020-12-15	9.21x
2020-12-14	10.77x
2020-12-11	10.77x
2020-12-10	10.77x
2020-12-09	10.77x
2020-12-08	10.77x
2020-12-07	10.77x
2020-12-04	12.32x
2020-12-03	12.32x
2020-12-02	12.32x
2020-12-01	10.77x
2020-11-30	10.77x
2020-11-27	10.77x
2020-11-25	12.32x
2020-11-24	12.32x
2020-11-23	10.77x
2020-11-20	12.32x
2020-11-19	12.32x
2020-11-18	12.32x
2020-11-17	12.32x
2020-11-16	12.32x
2020-11-13	10.77x
2020-11-12	13.88x
2020-11-11	12.32x
2020-11-10	13.88x
2020-11-09	15.44x
2020-11-06	17.00x
2020-11-05	17.00x
2020-11-04	17.00x
2020-11-03	13.88x
2020-11-02	13.88x
2020-10-30	13.88x
2020-10-29	13.88x
2020-10-28	13.88x
2020-10-27	13.88x
2020-10-26	13.88x
2020-10-23	15.44x
2020-10-22	15.44x
2020-10-21	15.44x
2020-10-20	15.44x
2020-10-19	17.00x
2020-10-16	15.44x
2020-10-15	15.44x
2020-10-14	15.44x
2020-10-13	13.88x
2020-10-12	17.00x
2020-10-09	15.44x
2020-10-08	12.32x
2020-10-07	15.44x
2020-10-06	15.44x
2020-10-05	15.44x
2020-10-02	17.00x
2020-10-01	17.00x
2019-03-29	86.65x
2019-03-28	82.76x
2019-03-27	86.65x
2019-03-26	90.54x
2019-03-25	82.76x
2019-03-22	86.65x
2019-03-21	82.76x
2019-03-20	109.97x
2019-03-19	102.20x
2019-03-18	106.09x
2019-03-15	106.09x
2019-03-14	106.09x
2019-03-13	109.97x
2019-03-12	109.97x
2019-03-11	98.31x
2019-03-08	98.31x
2019-03-07	94.42x
2019-03-06	90.54x
2019-03-05	86.65x
2019-03-04	90.54x
2019-03-01	94.42x
2019-02-28	90.54x
2019-02-27	94.42x
2019-02-26	94.42x
2019-02-25	90.54x
2019-02-22	86.65x
2019-02-21	86.65x
2019-02-20	82.76x
2019-02-19	82.76x
2019-02-15	74.99x
2019-02-14	74.99x
2019-02-13	71.10x
2019-02-12	71.10x
2019-02-11	71.10x
2019-02-08	78.87x
2019-02-07	71.10x
2019-02-06	71.10x
2019-02-05	74.99x
2019-02-04	74.99x
2019-02-01	74.99x
2019-01-31	71.10x
2019-01-30	71.10x
2019-01-29	78.87x
2019-01-28	71.10x
2019-01-25	82.76x
2019-01-24	71.10x
2019-01-23	78.87x
2019-01-22	78.87x
2019-01-18	86.65x
2019-01-17	74.99x
2019-01-16	78.87x
2019-01-15	74.99x
2019-01-14	74.99x
2019-01-11	71.10x
2019-01-10	78.87x
2019-01-09	86.65x
2019-01-08	82.76x
2019-01-07	78.87x
2019-01-04	74.99x
2019-01-03	67.21x
2019-01-02	78.87x

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics

EV/EBITDA Ratio: N/A

PMN EV/EBITDA Ratio Chart

PMN Average EV/EBITDA Ratio Chart

PMN EV/EBITDA Ratio Metrics

PMN Competitors' EV/EBITDA Ratio

EV/EBITDA Ratio Formula & Definition

EV/EBITDA Ratio FAQ

PMN EV/EBITDA Ratio History

Related Metrics